Pineal gland dysfunction in Alzheimer's disease: relationship with the immune-pineal axis, sleep disturbance, and neurogenesis.
Juhyun SongPublished in: Molecular neurodegeneration (2019)
Alzheimer's disease (AD) is a globally common neurodegenerative disease, which is accompanied by alterations to various lifestyle patterns, such as sleep disturbance. The pineal gland is the primary endocrine organ that secretes hormones, such as melatonin, and controls the circadian rhythms. The decrease in pineal gland volume and pineal calcification leads to the reduction of melatonin production. Melatonin has been reported to have multiple roles in the central nervous system (CNS), including improving neurogenesis and synaptic plasticity, suppressing neuroinflammation, enhancing memory function, and protecting against oxidative stress. Recently, reduced pineal gland volume and pineal calcification, accompanied by cognitive decline and sleep disturbances have been observed in AD patients. Here, I review current significant evidence of the contribution of pineal dysfunction in AD to the progress of AD neuropathology. I suggest new insights to understanding the relationship between AD pathogenesis and pineal gland function.
Keyphrases
- cognitive decline
- oxidative stress
- physical activity
- end stage renal disease
- chronic kidney disease
- mild cognitive impairment
- sleep quality
- metabolic syndrome
- traumatic brain injury
- ejection fraction
- type diabetes
- signaling pathway
- brain injury
- weight loss
- peritoneal dialysis
- prognostic factors
- lps induced
- heat stress
- induced apoptosis
- cerebrospinal fluid
- diabetic rats